1. Home
  2. Marc Arbyn
  3. Marc Arbyn

Primaire tabs

Zoeken
Limit to
Exporteer 215 resultaten:
Filters: Auteur is M. Arbyn
2016
Analytical performance evaluation of Anyplex II HPV28 and Euroarray HPV for genotyping of cervical samples., Latsuzbaia, Ardashel, Tapp Jessica, Nguyen Trung, Fischer Marc, Arbyn M., Weyers Steven, and Mossong Joel , Diagn Microbiol Infect Dis, 2016 Jul, Volume 85, Issue 3, p.318-322, (2016)
ANOVA model for network meta-analysis of diagnostic test accuracy data., Nyaga, Victoria N., Aerts Marc, and Arbyn M. , Stat Methods Med Res, 2016 Sep 20, (2016)
Barriers and opportunities for return-to-work of cancer survivors: time for action--rapid review and expert consultation., Kiasuwa, Regine, Otter Renée, Mortelmans Katrien, Arbyn M., Van Oyen Herman, Bouland Catherine, and De Brouwer Christophe , Syst Rev, 2016 Feb 24, Volume 5, p.35, (2016)
Clinical and analytical performance of the PapilloCheck HPV-Screening assay using the VALGENT framework., Heard, I, Cuschieri K, Geraets D T., Quint W, and Arbyn M. , J Clin Virol, 2016 Aug, Volume 81, p.6-11, (2016)
Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway-PaVDaG study)., Stanczuk, Grazyna, Baxter Gwendoline, Currie Heather, Lawrence James, Cuschieri Kate, Wilson Allan, and Arbyn M. , BMJ Open, 2016 Apr 25, Volume 6, Issue 4, p.e010660, (2016)
Correction for Geraets et al., Clinical Evaluation of a GP5+/6+-Based Luminex Assay Having Full High-Risk Human Papillomavirus Genotyping Capability and an Internal Control., Geraets, D T., Cuschieri K, de Koning M N. C., van Doorn L J., Snijders P J. F., Meijer C J. L. M., Quint W G. V., and Arbyn M. , J Clin Microbiol, 2016 Jul, Volume 54, Issue 7, p.1927, (2016)
Direct comparison of two vaginal self-sampling devices for the detection of human papillomavirus infections., Jentschke, M, Chen K, Arbyn M., Hertel B, Noskowicz M, Soergel P, and Hillemanns P , J Clin Virol, 2016 Sep, Volume 82, p.46-50, (2016)
Enrolment of young women attending cervical cancer screening to survey effectiveness of HPV vaccination., Arbyn, M., Broeck Davy Vanden, Bogers Johannes, Van Damme Pierre, Temmerman Marleen, and Weyers Steven , Cancer Epidemiol, 2016 Dec, Volume 45, p.178-179, (2016)
High-risk HPV testing in the management of atypical glandular cells: A systematic review and meta-analysis., Verdoodt, Freija, Jiang Xuezhi, Williams Mark, Schnatz Peter F., and Arbyn M. , Int J Cancer, 2016 Jan 15, Volume 138, Issue 2, p.303-10, (2016)
HPV testing in the context of post-treatment follow up (test of cure)., Cuschieri, Kate, Bhatia Ramya, Cruickshank Margaret, Hillemanns Peter, and Arbyn M. , J Clin Virol, 2016 Mar, Volume 76 Suppl 1, p.S56-S61, (2016)
HPV-FASTER: broadening the scope for prevention of HPV-related cancer., F Bosch, Xavier, Robles Claudia, Diaz Mireia, Arbyn M., Baussano Iacopo, Clavel Christine, Ronco Guglielmo, Dillner Joakim, Lehtinen Matti, Petry Karl-Ulrich, et al. , Nat Rev Clin Oncol, 2016 02, Volume 13, Issue 2, p.119-32, (2016)
Performance of a Cartridge-Based Assay for Detection of Clinically Significant Human Papillomavirus (HPV) Infection: Lessons from VALGENT (Validation of HPV Genotyping Tests)., Cuschieri, Kate, Geraets Daan, Cuzick Jack, Cadman Louise, Moore Catherine, Broeck Davy Vanden, Padalko Elisaveta, Quint Wim, and Arbyn M. , J Clin Microbiol, 2016 Sep, Volume 54, Issue 9, p.2337-42, (2016)
Reply to HPV test results provide useful risk stratification information in women with ASC-H Pap test findings., Arbyn, M., Xu Lan, and Wentzensen Nicolas , Cancer, 2016 Oct, Volume 124, Issue 10, p.754-755, (2016)
Surveillance of effects of HPV vaccination in Belgium., Arbyn, M., Broeck Davy Vanden, Benoy Ina, Bogers Johannes, Depuydt Christophe, Praet Marleen, De Sutter Philippe, Hoorens Anne, Hauben Esther, Poppe Willy, et al. , Cancer Epidemiol, 2016 Apr, Volume 41, p.152-8, (2016)
Triage of ASC-H: A meta-analysis of the accuracy of high-risk HPV testing and other markers to detect cervical precancer., Xu, Lan, Verdoodt Freija, Wentzensen Nicolas, Bergeron Christine, and Arbyn M. , Cancer Cytopathol, 2016 Apr, Volume 124, Issue 4, p.261-72, (2016)
Triage of HPV positive women in cervical cancer screening., Wentzensen, Nicolas, Schiffman Mark, Palmer Timothy, and Arbyn M. , J Clin Virol, 2016 Mar, Volume 76 Suppl 1, p.S49-S55, (2016)
VALGENT: A protocol for clinical validation of human papillomavirus assays., Arbyn, M., Depuydt Christophe, Benoy Ina, Bogers Johannes, Cuschieri Kate, Schmitt Markus, Pawlita Michael, Geraets Daan, Heard Isabelle, Gheit Tarik, et al. , J Clin Virol, 2016 Mar, Volume 76 Suppl 1, p.S14-S21, (2016)
Why follow-back studies should be interpreted cautiously: The case of an HPV-negative cervical lesion., Rossi, Paolo Giorgi, Ronco Guglielmo, Dillner Joakim, Elfström K Miriam, Snijders Peter J. F., Arbyn M., Berkhof Johannes, Carozzi Francesca, Del Mistro Annarosa, de Sanjosé Silvia, et al. , Cancer Cytopathol, 2016 Jan, Volume 124, Issue 1, p.66-7, (2016)
World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer., Santesso, Nancy, Reem Mustafa A., Schünemann Holger J., Arbyn M., Blumenthal Paul D., Cain Joanna, Chirenje Michael, Denny Lynette, De Vuyst Hugo, Eckert Linda O. 'Neal, et al. , Int J Gynaecol Obstet, 2016 Mar, Volume 132, Issue 3, p.252-8, (2016)
2015
Barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23-60 years., Östensson, Ellinor, Alder Susanna, Elfström K Miriam, Sundström Karin, Zethraeus Niklas, Arbyn M., and Andersson Sonia , PLoS One, 2015, Volume 10, Issue 5, p.e0128270, (2015)
Cervical cancer screening by human papillomavirus testing followed by cytology triage., Giorgi-Rossi, Paolo, Arbyn M., and Meijer Chris J. L. M. , JAMA Intern Med, 2015 Jun, Volume 175, Issue 6, p.1068, (2015)
Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II: Update on HPV primary screening., Arbyn, M., Haelens A., Desomer A., Verdoodt F., Thiry N., Francart J., Hanquet G., and Robays J. , KCE Report, (2015)
Clinical and Analytical Performance of the Onclarity HPV Assay Using the VALGENT Framework., Cuschieri, K, Geraets D T., Moore C, Quint W, Duvall E, and Arbyn M. , J Clin Microbiol, 2015 Oct, Volume 53, Issue 10, p.3272-9, (2015)
Colposcopy training and assessment across the member countries of the European Federation for Colposcopy., Moss, E L., Redman C W. E., Arbyn M., Dollery E, Petry K U., Nieminen P, Myerson N, and Leeson S C. , Eur J Obstet Gynecol Reprod Biol, 2015 May, Volume 188, p.124-8, (2015)
Early effects of human papillomavirus vaccination in Belgium., Merckx, Mireille, Broeck Davy Vanden, Benoy Ina, Depuydt Christophe, Weyers Steven, and Arbyn M. , Eur J Cancer Prev, 2015 Jul, Volume 24, Issue 4, p.340-2, (2015)

QR code

QR code for this page URL